HIGHLIGHTS
- who: F.E.V. Scheijmans from the of Dermatology and Allergology, Laboratory of Translational Immunologyof Dermatology and Allergology, Laboratory of Translational Immunology have published the research: Inflammatory markers in cerebrospinal fluid of paediatric spinal muscular atrophy patients receiving nusinersen treatment, in the Journal: (JOURNAL)
- what: The authors used a two-stage experimental design. This study was performed in small numbers of SMA patients receiving lower doses of nusinersen and found no abnormalities for these cytokines at day 7 and 28 post-dose, although no further details were provided . Interestingly, in the current paper, the authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.